Sign in Check my fit
EN
Home / US Department of Defense / HT942526OCRPCTA

DoW Ovarian Cancer, Clinical Trial Award

Open now · Grant · HT942526OCRPCTA

Next cut-off
01 Oct '26
in 25 days
Per grant
$2.8M
the call's own average
Grants expected
2
projects that will be funded
Funding rate
,
not published, read the conditions

In context of US Department of Defense

This grant$2.8M
The track runs to the largest grant in US Department of Defense ($1000M). The median across the 126 calls we publish is $1.5M, this one is above it.

What this call funds

Summary: The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.

Distinctive Features: Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

What applying costs you

ItemEstimateNote
Drafting effort3–4 weekssingle submission
Time to first payment6–9 monthscut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Also open in DOD

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit